BOSTAL DRUG
GenericsBOSTAL DRUG is a generic drug manufacturer focused on Metabolic.
BOSTAL DRUG's Key Drugs
BOSTAL DRUG's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
BOSTAL DRUG's Recent FDA Approvals
New NDA/BLA approvals for BOSTAL DRUG over the last two years — novel drugs only, excluding generics and label supplements.
BOSTAL DRUG's Therapeutic Areas
BOSTAL DRUG's approved drugs and pipeline span 1 therapeutic area, led by Metabolic. Weighted by commercial stage — approved drugs count most, then late-stage trials.
BOSTAL DRUG's Top Competitors
BOSTAL DRUG's closest competitors by therapeutic-area and drug-target overlap include Merck, Baxter, and Johnson & Johnson. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
BOSTAL DRUG Pipeline Snapshot
BOSTAL DRUG has 1 active clinical program from ClinicalTrials.gov — 0 Phase 3, 0 Phase 2 and 1 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Metabolic pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2026-08-11
- Latest
- 2026-08-11
- Applications
- 1